Addressing the research gap in IBD and MASLD: Time for coordinated action.
作者信息
Alfaraj Noora H, Teriaky Anouar, Qumosani Karim
机构信息
Department of Medicine, Qatif Health Network, Eastern Health Cluster, Qatif, Saudi Arabia.
Division of Gastroenterology, Department of Medicine, Western University, London Health Sciences Center, London, Canada.
出版信息
Saudi J Gastroenterol. 2025 May 1;31(3):105-106. doi: 10.4103/sjg.sjg_123_25. Epub 2025 May 6.
Abstract
摘要
相似文献
1
Addressing the research gap in IBD and MASLD: Time for coordinated action.填补炎症性肠病和非酒精性脂肪性肝病的研究空白：采取协调行动的时候了。
Saudi J Gastroenterol. 2025 May 1;31(3):105-106. doi: 10.4103/sjg.sjg_123_25. Epub 2025 May 6.
2
Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut-Liver Axis.非酒精性脂肪性肝病合并炎症性肠病：探索代谢功能障碍与肠-肝轴的交叉点
Life (Basel). 2025 Feb 12;15(2):288. doi: 10.3390/life15020288.
3
Long-Term Risk of Inflammatory Bowel Disease With MASLD: A Large-Scale Prospective Cohort Study in UK Biobank.伴有代谢相关脂肪性肝病的炎症性肠病的长期风险：英国生物银行的一项大规模前瞻性队列研究
J Gastroenterol Hepatol. 2025 Apr;40(4):855-865. doi: 10.1111/jgh.16880. Epub 2025 Jan 19.
4
Metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease: prevalence, risk factors, pathophysiological pathways and clinical consequences.炎症性肠病中代谢功能障碍相关脂肪性肝病：患病率、危险因素、病理生理途径及临床后果
Expert Rev Clin Immunol. 2025 Jul;21(7):875-891. doi: 10.1080/1744666X.2025.2514605. Epub 2025 Jun 16.
5
Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals.炎症性肠病是瘦人代谢功能障碍相关脂肪性肝病的独立危险因素。
Inflamm Bowel Dis. 2024 Aug 1;30(8):1274-1283. doi: 10.1093/ibd/izad175.
6
Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study.炎症性肠病患者的代谢功能障碍相关脂肪性肝病：一项初步研究。
Life (Basel). 2024 Sep 25;14(10):1226. doi: 10.3390/life14101226.
7
Dysbiosis of the gut micro-flora aggravates symptoms and accelerates disease progression in MASLD-IBD Co-morbid mice through host-microbial metabolic imbalance.肠道微生物群失调通过宿主-微生物代谢失衡加重MASLD-IBD共病小鼠的症状并加速疾病进展。
Arch Biochem Biophys. 2025 Jul;769:110441. doi: 10.1016/j.abb.2025.110441. Epub 2025 May 2.
8
Long-term risk of cardiovascular disease associated with MASLD and different cardiometabolic risk factors in IBD patients: A prospective cohort study.炎症性肠病患者 MASLD 与不同心血管代谢危险因素相关的长期心血管疾病风险：一项前瞻性队列研究。
Liver Int. 2024 Sep;44(9):2315-2328. doi: 10.1111/liv.15999. Epub 2024 May 31.
9
When metabolic comorbidities and risk of malnutrition coexist: The new era of inflammatory bowel disease.当代谢合并症与营养不良风险并存时：炎症性肠病的新时代。
Am J Med Sci. 2025 Jan;369(1):53-61. doi: 10.1016/j.amjms.2024.07.036. Epub 2024 Aug 2.
10
Mortality risk associated with MASLD, MASLD type and different cardiometabolic risk factors in IBD patients: A long-term prospective cohort study.IBD患者中与MASLD、MASLD类型及不同心脏代谢危险因素相关的死亡风险：一项长期前瞻性队列研究
Dig Liver Dis. 2025 Mar;57(3):744-752. doi: 10.1016/j.dld.2024.11.002. Epub 2024 Nov 24.
本文引用的文献
1
A bibliometric analysis of a decade's research on metabolic dysfunction-associated steatotic liver disease in the Arab world.阿拉伯世界关于代谢功能障碍相关脂肪性肝病十年研究的文献计量分析。
Saudi J Gastroenterol. 2025 May 1;31(3):157-167. doi: 10.4103/sjg.sjg_431_24. Epub 2025 Mar 3.
2
A bibliometric analysis of inflammatory bowel disease research in the Arab world.阿拉伯世界炎症性肠病研究的文献计量分析。
Saudi J Gastroenterol. 2025 May 1;31(3):146-156. doi: 10.4103/sjg.sjg_303_24. Epub 2024 Dec 11.
3
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa.中东和北非地区代谢功能障碍相关脂肪性肝病的患病率
Liver Int. 2024 Apr;44(4):1061-1070. doi: 10.1111/liv.15852. Epub 2024 Feb 2.
4
Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma.非酒精性脂肪性肝病包括肝硬化和肝细胞癌的肝脏结局。
Clin Liver Dis. 2023 May;27(2):211-223. doi: 10.1016/j.cld.2023.01.019. Epub 2023 Mar 9.
5
Changes in the global, regional, and national burdens of NAFLD from 1990 to 2019: A systematic analysis of the global burden of disease study 2019.1990年至2019年非酒精性脂肪性肝病的全球、区域和国家负担变化：全球疾病负担研究2019的系统分析
Front Nutr. 2022 Dec 21;9:1047129. doi: 10.3389/fnut.2022.1047129. eCollection 2022.
6
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担：2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
7
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.21 世纪全球炎症性肠病的发病率和流行率：基于人群的系统综述研究。
Lancet. 2017 Dec 23;390(10114):2769-2778. doi: 10.1016/S0140-6736(17)32448-0. Epub 2017 Oct 16.
Zotero 插件